Four-month rifapentine-moxifloxacin tuberculosis (TB) treatment regimen: Considerations for specific groups of people with TB disease
Public Domain
-
02/24/2022
Details
-
Description:This poster important information for health care providers to consider when using the 4-month rifapentine-moxifloxacin regimen as an option to treat people with drug-susceptible pulmonary TB disease.
-
Document Type:
-
CIO:
-
Division:
-
Location:
-
Collection(s):
-
Main Document Checksum:urn:sha256:415ed63b8b31e19f9b40e7a60558c1709cf7c53a259d03f89ae08f9c78aa4e50
-
Download URL:
-
File Type:
[PDF
- 232.66 KB
]
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.